◄ back to all posts
Financial data and stock pages provided by
Fintel.io
PFE: Pfizer, Inc. Stock
Written by | Jul 6, 2018
Print FriendlySIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 191,781.91 |
| Enterprise Value ($M) | 225,241.61 |
| Book Value ($M) | 58,806.00 |
| Book Value / Share | 10.58 |
| Price / Book | 3.18 |
| NCAV ($M) | -50,973.00 |
| NCAV / Share | -9.17 |
| Price / NCAV | -3.66 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.11 |
| Return on Assets (ROA) | 0.07 |
| Return on Equity (ROE) | 0.16 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.27 |
| Current Ratio | 1.54 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 45,290.00 |
| Assets | 155,000.00 |
| Liabilities | 96,263.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | n/a |
| Net Income | 11,188.00 |
| Earnings Per Share Diluted | 1.87 |
| Earnings Per Share Basic | 1.90 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 15,827.00 |
| Cash from Investing | 4,525.00 |
| Cash from Financing | 4,525.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | State Street Corp | 5.28 | -1.21 | |
| 13G/A | Vanguard Group Inc | 8.13 | -0.36 | |
| 13G/A | BlackRock Inc. | 7.70 | -7.91 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| PFE / Pfizer, Inc. 10-K – Annual Report – 10-K | ||
| PFE / Pfizer, Inc. 10-Q – Quarterly Report – 10-Q | ||
| PFE / Pfizer, Inc. 10-Q – Quarterly Report – 10-Q | ||
| PFE / Pfizer, Inc. 10-Q Quarterly Report 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,438,566 | 38,428,000 | 6.35 | |
| 3,310,509 | 31,154,900 | 10.63 | |
| 1,698,924 | 25,794,000 | 6.59 | |
| 2,355,360 | 25,341,100 | 9.29 | |
(click for more detail) |
|||
(click for list of largest short owners) |
|||
| Similar Companies | |
|---|---|
| MNK – Mallinckrodt PLC | MRK – Merck & Co., Inc. |
| PBH – Prestige Brands Holdings, Inc. | PRGO – Perrigo Company plc |
| USNA – USANA Health Sciences, Inc. |
Financial data and stock pages provided by
Fintel.io
